Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

200 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer

NCT00628251

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Boca Raton, Florida, United States
  • Research Site Boston, Massachusetts, United States
View all 24 locations
View Trial Details
Completed

Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer

NCT02751918

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Oklahoma University Health Science Center Oklahoma City, Oklahoma, United States
  • UZ Leuven Gasthuisberg Leuven, Belgium
View Trial Details
Completed

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

NCT01478685

Conditions
Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +49 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 13 locations
View Trial Details
Completed

A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer

NCT00913835

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • ImClone Investigational Site Joliet, Illinois, United States
  • ImClone Investigational Site Indianapolis, Indiana, United States
  • ImClone Investigational Site Baltimore, Maryland, United States
  • ImClone Investigational Site Boston, Massachusetts, United States
View Trial Details
Completed

The SOCQER-2 Study Surgery in Ovarian Cancer - Quality of Life Evaluation Research

NCT02569983

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • Ysbyty Gwynedd Bangor, United Kingdom
  • Birmingham City Hospital Birmingham, United Kingdom
  • Leeds General Infirmary Leeds, United Kingdom
  • Imperial Hospital NHS Trust London, United Kingdom
View all 14 locations
View Trial Details
Completed

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT01846611

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Scottsdale, Arizona, United States
  • Sedona, Arizona, United States
View all 138 locations
View Trial Details

Related conditions